TRIB (Trinity Biotech plc) Stock Analysis - SEC Filings

Trinity Biotech plc (TRIB) is a publicly traded Healthcare sector company. As of May 21, 2026, TRIB trades at $0.59 with a market cap of $11.54M and a P/E ratio of 0.00. TRIB moved +6.65% today. Year to date, TRIB is -20.85%; over the trailing twelve months it is -25.11%. Its 52-week range spans $0.48 to $3.44. Rallies surfaces TRIB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find TRIB SEC filings?

Rallies organizes TRIB SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

TRIB Key Metrics

Key financial metrics for TRIB
MetricValue
Price$0.59
Market Cap$11.54M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.22%
52-Week High$3.44
52-Week Low$0.48
Volume170
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest TRIB News

Recent TRIB Insider Trades

  • ROBERT R MCCORMICK TRIBUNE FOUNDATION sold 17.80K (~$924.52K) on Feb 18, 2004.
  • ROBERT R MCCORMICK TRIBUNE FOUNDATION sold 92.00K (~$4.82M) on Feb 17, 2004.
  • ROBERT R MCCORMICK TRIBUNE FOUNDATION sold 65.20K (~$3.39M) on Feb 13, 2004.

TRIB Analyst Consensus

TRIB analyst coverage data. Average price target: $0.00.

Common questions about TRIB

Where can I find TRIB SEC filings?
Rallies organizes TRIB SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show TRIB 10-K and 10-Q filings?
Rallies organizes TRIB SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is TRIB research on Rallies investment advice?
No. Rallies provides research, data, and educational context for TRIB. It does not provide personalized investment advice.
TRIB

TRIB